Tag: Spinocerebellar ataxia type 1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Spinocerebellar ataxia type 1

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance ...

Added to Collection on: 2020-07-28 15:01:47

Tags for this article:

Rare diseases

Netherlands

Branches of biology

Neurological disorders

Neurodegeneration

Spinocerebellar ataxia

Huntington's disease

Neurodegenerative disorders

Autosomal dominant disorders

Organ systems

Trinucleotide repeat disorders

Spinocerebellar ataxia type 1

Click the tags to see associated articles and topics

View Article Details

Identification of a regulatory pathway inhibiting adipogenesis via RSPO2 | Nature Metabolism

Added to Collection on: 2022-01-13 16:35:45

Tags for this article:

Branches of biology

Biology

Transcription factors

Spinocerebellar ataxia type 1

Adipose tissue

Peroxisome proliferator-activated receptor gamma

Cellular differentiation

Click the tags to see associated articles and topics

View Article Details

Detection of repeat expansions in large next generation DNA and RNA sequencing data ...

Added to Collection on: 2022-07-30 12:24:51

Tags for this article:

Branches of biology

Neurological disorders

Trinucleotide repeat disorders

Medical genetics

Rare diseases

Autosomal dominant disorders

Spinocerebellar ataxia type 1

Click the tags to see associated articles and topics

View Article Details

Vico Therapeutics Appoints Scott Schobel, MD as Chief Medical Officer - PR Newswire

Added to Collection on: 2022-10-03 06:53:50

Tags for this article:

Autosomal dominant disorders

Genetic genealogy

Medical genetics

Rare diseases

Trinucleotide repeat disorders

Clinical medicine

Neurodegenerative disorders

Spinocerebellar ataxia type 1

Huntington's disease

Spinocerebellar ataxia

Scott Schobel

Click the tags to see associated articles and topics

View Article Details

Tag: Spinocerebellar ataxia type 1

Recent Related Articles to Spinocerebellar ataxia type 1

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance ...

Identification of a regulatory pathway inhibiting adipogenesis via RSPO2 | Nature Metabolism

Detection of repeat expansions in large next generation DNA and RNA sequencing data ...

Vico Therapeutics Appoints Scott Schobel, MD as Chief Medical Officer - PR Newswire

Create dashboard for Tag: Spinocerebellar ataxia type 1